{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:59:58Z","timestamp":1790481598526,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004358","name":"Samsung","doi-asserted-by":"publisher","award":["EY01765"],"award-info":[{"award-number":["EY01765"]}],"id":[{"id":"10.13039\/100004358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21EY026148"],"award-info":[{"award-number":["R21EY026148"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY028996"],"award-info":[{"award-number":["R01EY028996"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F32CA210482"],"award-info":[{"award-number":["F32CA210482"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.actbio.2019.07.054","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T16:41:24Z","timestamp":1564504884000},"page":"451-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization"],"prefix":"10.1016","volume":"97","author":[{"given":"Jayoung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Lima e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron B.","family":"Shmueli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam C.","family":"Mirando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephany Y.","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niranjan B.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elana","family":"Ben-Akiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander S.","family":"Popel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Campochiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4176-3808","authenticated-orcid":false,"given":"Jordan J.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2019.07.054_b0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.addr.2016.11.003","article-title":"Gene delivery nanoparticles to modulate angiogenesis","volume":"119","author":"Kim","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.actbio.2019.07.054_b0010","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0161-6420(92)31871-8","article-title":"Prevalence of age-related maculopathy. The Beaver Dam eye study","volume":"99","author":"Klein","year":"1992","journal-title":"Ophthalmology"},{"issue":"17 Suppl 12","key":"10.1016\/j.actbio.2019.07.054_b0015","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.2146\/ajhp070330","article-title":"Etiology and natural history of diabetic retinopathy: an overview","volume":"64","author":"Morello","year":"2007","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"2","key":"10.1016\/j.actbio.2019.07.054_b0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/gt.2011.164","article-title":"Gene transfer for ocular neovascularization and macular edema","volume":"19","author":"Campochiaro","year":"2012","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.actbio.2019.07.054_b0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O'Reilly","year":"1997","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.actbio.2019.07.054_b0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","article-title":"Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma","volume":"79","author":"O'Reilly","year":"1994","journal-title":"Cell"},{"issue":"37","key":"10.1016\/j.actbio.2019.07.054_b0035","doi-asserted-by":"crossref","first-page":"13775","DOI":"10.1073\/pnas.0803241105","article-title":"A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells","volume":"105","author":"Karagiannis","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"12","key":"10.1016\/j.actbio.2019.07.054_b0040","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1593\/neo.09620","article-title":"Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts","volume":"11","author":"Koskimaki","year":"2009","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.actbio.2019.07.054_b0045","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1593\/tlo.11244","article-title":"Serpin-derived peptides are antiangiogenic and suppress breast tumor xenograft growth","volume":"5","author":"Koskimaki","year":"2012","journal-title":"Transl. Oncol."},{"issue":"7","key":"10.1016\/j.actbio.2019.07.054_b0050","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/CAD.0b013e3283531041","article-title":"Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth","volume":"23","author":"Rosca","year":"2012","journal-title":"Anticancer Drugs"},{"issue":"2","key":"10.1016\/j.actbio.2019.07.054_b0055","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1593\/neo.121638","article-title":"Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A","volume":"15","author":"Lee","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.actbio.2019.07.054_b0060","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.1038\/srep07139","article-title":"Inhibition of breast cancer growth and metastasis by a biomimetic peptide","volume":"4","author":"Lee","year":"2014","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.actbio.2019.07.054_b0065","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1167\/iovs.08-2607","article-title":"A peptide derived from type 1 thrombospondin repeat-containing protein WISP-1 inhibits corneal and choroidal neovascularization","volume":"50","author":"Cano Mdel","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"30","key":"10.1016\/j.actbio.2019.07.054_b0070","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.1016\/j.biomaterials.2013.06.044","article-title":"Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide","volume":"34","author":"Shmueli","year":"2013","journal-title":"Biomaterials"},{"issue":"373","key":"10.1016\/j.actbio.2019.07.054_b0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai8030","article-title":"Tyrosine kinase blocking collagen IV-derived peptide suppresses ocular neovascularization and vascular leakage","volume":"9","author":"Lima e Silva","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"5\u20136","key":"10.1016\/j.actbio.2019.07.054_b0080","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/08820538.2014.962167","article-title":"Complications of intravitreal injections in patients with diabetes","volume":"29","author":"Shikari","year":"2014","journal-title":"Semin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.actbio.2019.07.054_b0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1747-0285.2012.01376.x","article-title":"Structure-activity relationship study of collagen-derived anti-angiogenic biomimetic peptides","volume":"80","author":"Rosca","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.actbio.2019.07.054_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12824","article-title":"Development of a dexamethasone intravitreal implant for the treatment of noninfectious posterior segment uveitis","volume":"1358","author":"Whitcup","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2019.07.054_b0095","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11095-008-9626-z","article-title":"Shape induced inhibition of phagocytosis of polymer particles","volume":"26","author":"Champion","year":"2009","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.actbio.2019.07.054_b0100","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/jbm.a.35399","article-title":"An automated multidimensional thin film stretching device for the generation of anisotropic polymeric micro- and nanoparticles","volume":"103","author":"Meyer","year":"2015","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"2","key":"10.1016\/j.actbio.2019.07.054_b0105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jcp.10246","article-title":"VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier","volume":"195","author":"Saishin","year":"2003","journal-title":"J. Cell Physiol."},{"issue":"12","key":"10.1016\/j.actbio.2019.07.054_b0110","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.actbio.2019.07.054_b0115","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0002-9440(10)65753-7","article-title":"Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model","volume":"153","author":"Tobe","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.actbio.2019.07.054_b0120","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/nprot.2013.135","article-title":"Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice","volume":"8","author":"Lambert","year":"2013","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.actbio.2019.07.054_b0125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jcp.1114","article-title":"Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization","volume":"188","author":"Mori","year":"2001","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.actbio.2019.07.054_b0130","first-page":"281","article-title":"Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization","volume":"151","author":"Okamoto","year":"1997","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.actbio.2019.07.054_b0135","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00006982-200110000-00003","article-title":"Retinal angiomatous proliferation in age-related macular degeneration","volume":"21","author":"Yannuzzi","year":"2001","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.actbio.2019.07.054_b0140","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2217\/nnm-2016-0379","article-title":"Drug delivery to the eye: what benefits do nanocarriers offer?","volume":"12","author":"Joseph","year":"2017","journal-title":"Nanomedicine (Lond)"},{"issue":"10","key":"10.1016\/j.actbio.2019.07.054_b0145","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1167\/iovs.16-21334","article-title":"Evaluation of the toxicity of intravitreally Injected PLGA microspheres and rods in monkeys and rabbits: effects of depot size on inflammatory response","volume":"58","author":"Thackaberry","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.actbio.2019.07.054_b0150","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2008.01.004","article-title":"Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres","volume":"127","author":"Zolnik","year":"2008","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.actbio.2019.07.054_b0155","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/pi.1697","article-title":"Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]","volume":"54","author":"Alexis","year":"2005","journal-title":"Polym. Int."},{"issue":"2","key":"10.1016\/j.actbio.2019.07.054_b0160","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0002-9440(10)64891-2","article-title":"Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment","volume":"160","author":"Ohno-Matsui","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.actbio.2019.07.054_b0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nnano.2007.70","article-title":"Shape effects of filaments versus spherical particles in flow and drug delivery","volume":"2","author":"Geng","year":"2007","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.actbio.2019.07.054_b0170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/2013.jamaophthalmol.91","article-title":"Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment","volume":"131","author":"Do","year":"2013","journal-title":"JAMA Ophthalmol."},{"issue":"2","key":"10.1016\/j.actbio.2019.07.054_b0175","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/bjophthalmol-2014-305327","article-title":"Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration","volume":"99","author":"Holz","year":"2015","journal-title":"Br. J. Ophthalmol."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706119305434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706119305434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:21:19Z","timestamp":1778624479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706119305434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":35,"alternative-id":["S1742706119305434"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2019.07.054","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2019.07.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}